Metraipolis › archive › dc_b3e20e19e4e4
Efgartigimod in the treatment of immune checkpoint inhibitor-related myasthenia gravis -myositis overlap syndrome: a case report — Europe PMC PMID:42529120
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42529120
- DOI
- 10.3389/fimmu.2026.1818836
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T06:31:03.803Z
- SHA-256 of the archived text
b77bceeda9c9207e485b7a6da5b5d837700c364013d0e5e2242ed19f15ff9a2c- Stable URL of this page
https://metraipolis.com/documento/dc_b3e20e19e4e4
How to cite
Efgartigimod in the treatment of immune checkpoint inhibitor-related myasthenia gravis -myositis overlap syndrome: a case report — Europe PMC PMID:42529120 — Europe PMC (en), https://europepmc.org/article/MED/42529120 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b3e20e19e4e4 (Metraipolis archive dc_b3e20e19e4e4, sha256 b77bceeda9c9207e485b7a6da5b5d837700c364013d0e5e2242ed19f15ff9a2c)
BibTeX
@misc{dcb3e20e19e4e4,
title = {Efgartigimod in the treatment of immune checkpoint inhibitor-related myasthenia gravis -myositis overlap syndrome: a case report — Europe PMC PMID:42529120},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42529120},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b3e20e19e4e4; sha256 b77bceeda9c9207e485b7a6da5b5d837700c364013d0e5e2242ed19f15ff9a2c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42529120. Agents can read the archived copy with the MCP tool read_document.